Isolation, characterization, in silico docking, and in vitro cytotoxicity study of isolated triterpene constituents from Ehretia microphylla
Authors/Creators
- 1. Department of Pharmaceutical Chemistry, KTN College of Pharmacy, Chalavara, Kerala, India
- 2. Department of Pharmaceutical Chemistry, Sri Venkateshwara College of Pharmacy, Ariyur, Pondicherry, India
- 3. Bioscience and Engineering, NIT Calicut, Kerala, India
Description
Building on previous studies of Ehretia microphylla, we quantified key
phytochemicals rutin, gallic acid, and quercetin using high-performance
thin-layer chromatography (HPTLC), validated against standard references.
From chloroform extract, three triterpenes were isolated and structurally
characterized. These were identified as bauerenol (Compound A), 11-oxo
amyrin (Compound B, a novel triterpene), and β-sitosterol (Compound C).
In silico docking studies were performed with the cancer-related protein
(PDB: 1DB1), yielding binding scores of −9.50, −9.44, and −7.44, and with
the hepatoprotective target (PDB: 4FA6), with scores of −8.13, −8.42, and
−8.54, respectively. Compounds A and B exhibited significant anticancer
potential, while Compound C showed superior hepatoprotective activity. In
vitro cytotoxicity studies on HepG2 cells revealed IC₅₀ values of 455, 538,
and 556 μg/mL, and on NIH 3T3 cells, IC₅₀ values were 1068, 1153, and
1310 μg/mL, indicating selective toxicity toward cancer cells. These findings
highlight the therapeutic potential of triterpenes from E. microphylla, with
Compounds A and B for hepatocellular carcinoma treatment and Compound
C for hepatoprotection.
Files
571-3114-1-PB.pdf
Files
(652.5 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:e75be9fa88eb56d133860d5abeb238bf
|
652.5 kB | Preview Download |
Additional details
Identifiers
Dates
- Accepted
-
2025-04-14